Related Experiment Video
Updated: Jun 13, 2026
08:17
Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Heart failure in the elderly: advances and challenges.
12C2 W.C. Mackenzie Health Sciences Centre, Division of Cardiology, Department of Medicine, University of Alberta and Hospitals, 8440-112 Street, Edmonton, AB, T6G 2B7, Canada. bjugdutt@ualberta.ca
Expert Review of Cardiovascular Therapy
|May 11, 2010
Summary
Heart failure treatment shows mortality benefits in elderly patients with reduced ejection fraction, but not preserved ejection fraction. Tailoring heart failure pharmacotherapy for older adults is crucial due to aging factors.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Background:
- The global elderly population is expanding, leading to increased heart failure prevalence, morbidity, hospitalizations, and healthcare costs.
- Current heart failure clinical trials lack specific data for elderly populations.
- Aging affects physiology, drug metabolism, and increases risks of comorbidities and polypharmacy, complicating treatment.
Purpose of the Study:
- To review the current understanding of heart failure management in the elderly.
- To highlight the challenges and considerations for heart failure pharmacotherapy in older adults.
- To identify gaps in research and suggest future directions for heart failure treatment in the elderly.
Main Methods:
- Literature review of clinical trials and studies on heart failure in elderly patients.
- Analysis of age-specific physiological changes, pharmacokinetics, and drug interactions.
- Examination of treatment benefits and risks in different heart failure subtypes.
Main Results:
- Therapies for heart failure with reduced ejection fraction (HFrEF) demonstrate mortality benefits in elderly patients, even when trials primarily included younger populations.
- Conversely, therapies for heart failure with preserved ejection fraction (HFpEF) have not shown mortality benefits in elderly or non-elderly patients.
- Individualized pharmacotherapy is essential, considering factors like aging physiology, comorbidities, polypharmacy, and drug-drug interactions.
Conclusions:
- Heart failure management in the elderly requires personalized approaches due to unique physiological and clinical factors.
- Further research into the biology of aging and dedicated clinical trials in elderly populations are necessary to develop novel heart failure therapies.
- Distinguishing between HFrEF and HFpEF is critical for effective treatment strategies in older adults.
Related Concept Videos
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...